Stay updated on EXN407 Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.

Latest updates to the EXN407 Safety & Tolerability Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Diabetic Macular Edema, while retaining the names of collaborators and the revision number.SummaryDifference27%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to EXN407 Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.